Characterization of a Major Antigenic Region on gp55 of Human Cytomegalovirus

References

1. Atassi M. Z., Kazim A. L., Sakata S. 1981; High yield coupling of peptides to protein carriers. Biochimica et biophysica acta 670:300–302
   [Google Scholar]
2. Britt W. J. 1984; Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135:369–378
   [Google Scholar]
3. Britt W. J., Auger D. 1986; Synthesis and processing of the envelope gp 55–116 complex of human cytomegalovirus. Journal of Virology 58:185–191
   [Google Scholar]
4. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
   [Google Scholar]
5. Dillner J., Dillner L., Robb J., Willems J., Jones I., Lancaster W., Smith R., Lerner R. 1989; A synthetic peptides defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences, U. S. A. 86:3838–3841
   [Google Scholar]
6. Fischer P. M., Merlin E. H. 1990; Direct enzyme-linked immunosorbent assay of anti-peptide antibodies using capture of biotinylated peptides by immobilized avidin. Journal of Immunoassay 11:311–327
   [Google Scholar]
7. Fridell E., Trojnar J., Wahren B. 1989; A new peptide for human parvovirus B19 antibody detection. Scandinavian Journal of Infectious Diseases 21:597–603
   [Google Scholar]
8. Geerligs H. J., Weijer W. J., Bloemhoff W., Welling G. W., Welling-Wester S. 1988; The influence of pH and ionic strength on the coating of peptides of herpes simplex type 1 in an enzyme-linked immunosorbent assay. Journal of Immunological Methods 106:239–244
   [Google Scholar]
9. Geysen H. M., Meloen R. H., Barteling S. J. 1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proceedings of the National Academy of Sciences, U. S. A. 81:3998–4002
   [Google Scholar]
10. Geysen H. M., Rodda S. J., Mason T. J., Tribbick G., Schoofs P. G. 1987; Strategies for epitope analysis using peptide synthesis. Journal of Immunological Methods 102:259–274
    [Google Scholar]
11. Gönczöl E., Hudecz F., Ianacone J., Dietzschold B., Starr S., Plotkin S. A. 1986; Immune responses to isolated human cytomegalovirus envelope proteins. Journal of Virology 58:661–664
    [Google Scholar]
12. Gönczöl E., Ianacone J., Furlini G., Ho W., Plotkin S. A. 1989; Humoral response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain. Journal of Infectious Diseases 159:851–859
    [Google Scholar]
13. Houghten R. A. 1985; General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences, U. S. A. 82:5131–5135
    [Google Scholar]
14. Houghten R. A., Bray M. K., DeGraw S. T., Kirby C. J. 1986; Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. International Journal of Peptide and Protein Research 27:673–678
    [Google Scholar]
15. Kennedy R. C., Dreesman G. R., Chanh T. C., Boswell R. N., Allan J. S., Lee T., Essex M., Sparrow J. T., Ho D. H., Kanda P. 1987; Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. Journal of Biological Chemistry 262:5769–5774
    [Google Scholar]
16. Kniess N., Mach M., Fay J., Britt W. J. 1991; Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalo-virus. Journal of Virology 65:138–146
    [Google Scholar]
17. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. 1985; Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. Journal of Medical Virology 17:303–311
    [Google Scholar]
18. Landini M. P., Severi B., Badiali L., Gönczöl E., Mirolo G. 1987; Structural component of human cytomegalovirus: in situ localization of the major glycoprotein. Intervirology 27:154–160
    [Google Scholar]
19. Mach M., Utz U., Fleckenstein B. 1986; Mapping of the major glycoprotein gene of human cytomegalovirus. Journal of General Virology 67:1461–1467
    [Google Scholar]
20. Masuho Y., Matsumoto Y. I., Sugano T., Fujinaga S., Minamishima Y. 1987; Human monoclonal antibodies neutralizing human cytomegalovirus. Journal of General Virology 68:1457–1461
    [Google Scholar]
21. Merrifield R. B. 1963; Solid phase synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85:2149–2154
    [Google Scholar]
22. Meyer H., Masuho Y., Mach M. 1990; The gp116 of the gp58/l16 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope. Journal of General Virology 71:2443–2450
    [Google Scholar]
23. Middeldorp J. M., Meloen R. H. 1988; Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligo-peptides. Journal of Virological Methods 21:147–159
    [Google Scholar]
24. Nowak B., Sullivan C., Sarnow P., Thomas R., Bricout F., Nicolas J. C., Fleckenstein B., Levine A. J. 1984; Characterization of monoclonal antibodies and polyclonal immune sera directed against cytomegalovirus virion proteins. Virology 132:325–338
    [Google Scholar]
25. Pereira L., Hoffman M., Tatsuno M., Dondero D. 1984; Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology 139:73–86
    [Google Scholar]
26. Pereira L., Ali M., Kousoulas K., Huo B., Banks T. 1989; Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172:11–24
    [Google Scholar]
27. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
    [Google Scholar]
28. Spear P. G. 1985; Glycoproteins specified by herpes simplex virus. In The Herpesviruses vol 3 pp 315–356 Edited by Roizman B., Lopez C. New York: Plenum Press;
    [Google Scholar]
29. Sundqvist V.-A., Wahren B. 1981; An interchangeable ELISA for cytomegalovirus antigen and antibody. Journal of Virological Methods 2:301–312
    [Google Scholar]
30. Tam J. P. 1988; Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proceedings of the National Academy of Sciences, U. S. A. 85:5409–5413
    [Google Scholar]
31. Twining S. S., Atassi M. Z. 1979; Use of immunosorbents for the study of antibody binding to sperm whale myoglobin and its synthetic antigenic sites. Journal of Immunological Methods 30:139–151
    [Google Scholar]
32. Utz U., Britt W. J., Vugler L., Mach M. 1989; Identification of a neutralizíng epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63:1995–2001
    [Google Scholar]
33. Wang J. J. G., Steel S., Wisniewolski R., Wang C. Y. 1986; Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proceedings of the National Academy of Sciences, U. S. A. 83:6159–6163
    [Google Scholar]